Open AccessIs It Safe to Stop Anti–PD-1 Immunotherapy in Patients With Metastatic Melanoma Who Achieve a Complete Response?
Author(s) -
Michael A. Davies
Publication year - 2020
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.20.00136
Subject(s) - medicine , metastatic melanoma , immunotherapy , melanoma , oncology , ipilimumab , complete response , cancer research , cancer , chemotherapy